Pharma News

The British drug-maker, AstraZeneca signed an exclusive deal with Beijing based Shenzhen Kangtai Biological Products Co., Ltd to manufacture a potential COVID-19 vaccine in mainland China.

Alembic Pharmaceuticals Limited announced that the Company has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Vardenafil Hydrochloride Tablets, 2.5 mg (base), 5 mg (base), 10 mg (base), and 20 mg (base).

There are more 471 FDCs relating to Vitamins, Minerals and Micronutrients, etc., which have been declared as rational by Prof. Kokate Committee and a report of the committee has been accepted by the Ministry. And CDSCO asks manufacturers to get licenses from State Licensing Authorities.

Health Ministry exempt hand sanitizers from requirement of sale licence under the provisions of Chapter IV of the Drugs and Cosmetics Act, 1940.

AbbVie announced that the Phase 3 ADVANCE trial evaluating the investigational medicine atogepant, an orally administered calcitonin gene-related peptide (CGRP) receptor antagonist (gepant) met its primary endpoint of statistically significantly greater reduction in mean monthly migraine days, compared to placebo, for all doses across the 12-week treatment period.